ClinicalTrialsFinder

Refractory B-Cell Non-Hodgkin Lymphoma Clinical Trials in Dallas, Texas

1 recruitingDallas, Texas

Showing 1–1 of 1 trials

Recruiting
Phase 1

CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy for Relapsed/Refractory B Cell Non-Hodgkin Lymphoma (ANTLER)

Lymphoma, Non-HodgkinRefractory B-Cell Non-Hodgkin LymphomaRelapsed Non Hodgkin Lymphoma
Caribou Biosciences, Inc.72 enrolled38 locationsNCT04637763